Epix Drops Depression Candidate After Second Study Failure
This article was originally published in The Pink Sheet Daily
Executive Summary
Alzheimer’s candidate in development with GlaxoSmithKline advances.
You may also be interested in...
Epix To Advance COPD, Alzheimer’s Drugs
Firm moving ahead after failed depression trial.
Epix To Advance COPD, Alzheimer’s Drugs
Firm moving ahead after failed depression trial.
GSK/Epix Alzheimer’s Drug Starts Phase IIb
Firm tries again with PRX-03140/donepezil combo.